Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Volume: 17, Issue: 11, Pages: 1805 - 1813
Published: Jun 25, 2014
Abstract
The N-methyl-D-aspartate glutamate receptor antagonist ketamine has demonstrated rapid antidepressant effects in treatment-resistant depression (TRD). However, evaluation of ketamine's neurocognitive aspects in TRD has started to be explored. This study aims to (1) examine baseline neurocognitive performance and change in severity of depressive symptoms through six ketamine infusions, (2) examine the neurocognitive effects after completion of...
Paper Details
Title
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Published Date
Jun 25, 2014
Volume
17
Issue
11
Pages
1805 - 1813
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History